Member Info for inanaco

Ivy.s new Friend

Ash Sarkar
@AyoCaesar
Contributing Editor
@novaramedia
. Literature bore. Anarcho-fabulous. Muslim. THFC. Walks like a supermodel. F...ks like a champion. Luxury communism now!

yes but that is different .,.....

The royalty itself is 100% profit .......... how you spend that is another matter

C7 .......... perhaps the need to squeeze Inanaco into a corner ....

hardly ...

they have the "group Hug"

Ivy is so determined to have a fight on Twitter he has joined the labour Party ... !! he is Now Comrade Ivy ...

BioNtech is a license ...

probably stage payments with a royalty at the end of it ...

but the cost attributed to the development of SCIB2 and TCR have already been accounted for in this 2018/19/20 accounts

so what costs would you apply if they start paying Royalties ............ None ... its already accounted for as a carry forward loss ... of which we have already funded and received Tax credits ..

Scancell policy is to license .......... indeed if SCIB2 completed all stages under this agreement and we did not take the license back at phase 2 ...... we would be in line for Royalties on sales on approval

straight to the bottom line ..............

means you can carry on investing ... R and D on other projects ... but this can be off set against the 100% profit from the Royalty ..
No Dilution or borrowings ...
i get a royalty cheque because the 25,000 volt line runs on my land ............ but i dont pay for the upkeep !!

simple stuff ...... why do you need an accountancy degree ?

inanaco,

I am mystified who might be paying the royalty - who are they? Do they have a sound financial footing?

VAL .......... all will be well

Nom ... if you have the Royalty cheque in your pocket, the legal stuff has already been done

Ruck explains his "deal" https://twitter.com/i/status/1197895373957808129

you mean you cannot explain ref Royalties

and you seem to have not considered the stage payments ... etc etc etc

Royalty income goes straight to the bottom line because the costs to develop the IP are all sunk and there is no marginal cost to let another business use the IP. If you're in an industry where the profit margin is 20%, then for every $100,000 of royalty income you generate you would need to make $500,000 in sales to deliver the same amount of profit.

No company makes 100% net profit!
What about buildings, salaries, manufacturing costs, further research, IT equipment, travel etc etc etc.

a Royalty goes straight to the bottom line ..

why do we have to manufacture it ?

really ...

in the adjuvant space name the "lot of players"

who is the competition ... Keytruda ...lol

so why 6.9 percent ... Market share

Royalty is 100% to the bottom line .... less the cost of banking the cheque

what is this 20% profit nonsense ?

what ever ....
"abbot Maths"

$4 billion of sales US alone = 25p a share ?

If it did get to market by say 2026, it could be worth 25p/share (SCIB1 alone based on a £4B market)

LOL ........... US = $4b

so worth 25p a share . ?

are you for real ?

The reason why i keep saying SCIB1 ... easily covers the Shareprice ... is because it does .........

the rest is a bonus ...

Tf please chill .. it will happen

Ruckrover ... Look at share price

I know you have your valuations ... which i find "simple" ....

here is one from Scancell

SCIB1 In combination with checkpoint inhibitors in patients with late stage disease to increase efficacy without
compromising safety
? As monotherapy in patients with resected disease (adjuvant setting) to delay or prevent recurrence
? 260,000 patients with stage IIB, IIC, and III melanoma, of which 45% can be treated with SCIB1* at an
estimated annual treatment cost of $40k representing a $4b market in the US alone

"What does the industry see that the market doesn"t??"

everything under NDA

all the latest developments on TCR

all the developments of SCIB2

all the developments on MABS

and hidden from all ...

all future patent applications